IL13RA2 and glioblastoma: This trispecific TCE was designed to address the tumor heterogeneity of glioblastoma and demonstrated efficient tumor growth control in a GBM model with heterogenous expression of IL13Rα2 and EGFRvIII, resembling the complex tumor environment in human GBM (34).